PHA-680632 100mg 100mg | Purity Not Available
Adooq Bioscience
PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PageSearch Results
PHA-680632 10mg 10mg | Purity Not Available
Adooq Bioscience
PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-665752 50mg 50mg | Purity Not Available
Adooq Bioscience
Danusertib 5mg 5mg | Purity Not Available
Adooq Bioscience
Danusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor
More Information Supplier PageDanusertib 50mg 50mg | Purity Not Available
Adooq Bioscience
Danusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor
More Information Supplier PagePhenoxybenzamine hydrochloride 100mg 100mg | Purity Not Available
Adooq Bioscience
Phenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenformin hydrochloride 500mg 500mg | Purity Not Available
Adooq Bioscience
Phenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePhenformin HCl 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Phenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePhenformin hydrochloride 1000mg 1000mg | Purity Not Available
Adooq Bioscience
Phenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePHA-793887 50mg 50mg | Purity Not Available
Adooq Bioscience
PHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier Page